Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Laurel Poole

Physician Assistant, Medical Joliet, IL Physician Assistant

NPI 1841252426 CMS profile 11080242

1124 Essington Rd, Joliet, IL 60435

Open in the dashboard

General payments

$8,841

505 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Laurel Poole of Joliet, IL is reported in the CMS Open Payments database as having received $8,841 across 505 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,610 163
2024 General $2,363 138
2023 General $1,583 107
2022 General $961 45
2021 General $1,324 52

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Laurel Poole
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Laurel Poole were reported at $2,610. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Laurel Poole Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $1,324 $156 $41–$563 $132
2022 $961 $185 $55–$649 $149
2023 $1,583 $199 $58–$717 $160
2024 $2,363 $206 $62–$740 $164
2025 $2,610 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,579 97 payments
  2. Sun Pharmaceutical Industries Inc. $1,040 51 payments
  3. Janssen Biotech, Inc. $815 42 payments
  4. Arcutis Biotherapeutics, Inc. $716 61 payments
  5. Lilly USA, LLC $644 37 payments
  6. Galderma Laboratories, L.P. $555 29 payments
  7. Dermavant Sciences, Inc. $463 46 payments
  8. Regeneron Healthcare Solutions, Inc. $348 12 payments
  9. Pfizer Inc. $308 15 payments
  10. PruGen, Inc. Pharmaceuticals $280 1 payment
  11. Other $2,095 114 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,517 498 payments
  2. Education $324 7 payments
Products named General payments · program years 2021–2025
  1. TREMFYA $766 39 payments
  2. ILUMYA $722 38 payments
  3. Zoryve $683 59 payments
  4. SKYRIZI $631 39 payments
  5. RINVOQ $620 36 payments
  6. VTAMA $484 48 payments
  7. TALTZ $361 24 payments
  8. AKLIEF $359 12 payments
  9. EBGLYSS $305 15 payments
  10. DUPIXENT $276 9 payments
  11. Other $5,283 294 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 20 drugs

Part D claims

1,083

Median for Physician Assistant: 241

Drug cost

$237,899

Median for Physician Assistant: $4,110

Branded share of claims

5.6%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Humira(Cf) Pen Adalimumab Brand 11 $141,674
Dupixent Pen Dupilumab Brand 17 $67,999
Clobetasol Propionate Generic 183 $9,636
Ketoconazole Generic 181 $2,772
Calcipotriene Generic 11 $2,341
Fluorouracil Generic 33 $2,124
Metronidazole Generic 48 $1,858
Triamcinolone Acetonide Generic 230 $1,687
Doxycycline Hyclate Generic 92 $1,657
Tacrolimus Generic 15 $1,419

The 10 drugs with the highest cost, of 20 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$334,992

Of which drugs: $150,365

Medicare patients

1,083

Average age 74

Services billed

6,202

706 women, 377 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 45%
Ischemic heart disease 22%
Diabetes 21%
Cancer 16%
Osteoporosis 16%
Chronic kidney disease 15%
Atrial fibrillation 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 12 16 $10

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 30 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Zoryve
  • Arcutis Biotherapeutics, Inc. $337
$337 — —
DUPIXENT
  • Regeneron Healthcare Solutions, Inc. $164
  • GENZYME CORPORATION $60
$224 17 —
VTAMA
  • Dermavant Sciences, Inc. $215
$215 — —
RINVOQ
  • AbbVie, Inc. $210
$210 — —
SKYRIZI
  • AbbVie, Inc. $194
$194 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 30 with Patron

Records

505 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record